ZOLPIDEM TARTRATE tablet, film coated

국가: 미국

언어: 영어

출처: NLM (National Library of Medicine)

유효 성분:

ZOLPIDEM TARTRATE (UNII: WY6W63843K) (ZOLPIDEM - UNII:7K383OQI23)

제공처:

Dr. Reddy's Laboratories Limited

INN (국제 이름):

ZOLPIDEM TARTRATE

구성:

ZOLPIDEM TARTRATE 5 mg

관리 경로:

ORAL

처방전 유형:

PRESCRIPTION DRUG

치료 징후:

Zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies (see CLINICAL STUDIES (14) ). The clinical trials performed in support of efficacy were 4-5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. Zolpidem tartrate tablets are contraindicated in patients with known hypersensitivity to zolpidem tartrate or to any of the inactive ingredients in the formulation. Observed reactions include anaphylaxis and angioedema (see WARNINGS AND PRECAUTIONS (5.2) ). Pregnancy Category C. There are no adequate and well-controlled studies  of zolpidem in pregnant women. Zolpidem tartrate should be used during pregnancy only if the potential benefit  justifies the potential risk to the fetus.  Administration of zolpidem to pregnant rats and rabbits resulted in adverse effects on off

제품 요약:

Zolpidem tartrate tablets 5 mg are light pink colored, capsule shaped, biconvex film coated tablets debossed 'RDY' on one side and '478' on other side. Bottles of 30                                                                 NDC 55111-478-30 Bottles of 60                                                                 NDC 55111-478-60 Bottles of 100                                                               NDC 55111-478-01 Bottles of 500                                                               NDC 55111-478-05 Blister card of 30 unit-dose                                           NDC 55111-478-81 Zolpidem tartrate tablets 10 mg are white colored, capsule shaped, biconvex film coated tablets debossed 'RDY' on one side and '479' on other side. Bottles of 30                                                                 NDC 55111-479-30 Bottles of 60                                                                 NDC 55111-479-60 Bottles of 100                                                               NDC 55111-479-01 Bottles of 500                                                               NDC 55111-479-05 Blister card of 30 unit-dose                                           NDC 55111-479-81 Store at 20°-25°C (68°-77°F); [See USP Controlled Room Temperature].

승인 상태:

Abbreviated New Drug Application

환자 정보 전단

ZOLPIDEM TARTRATE- ZOLPIDEM TARTRATE TABLET, FILM COATED
Dr. Reddy's Laboratories Limited
----------
17.4 MEDICATION GUIDE
MEDICATION GUIDE
Zolpidem Tartrate Tablets C-IV
Read the Medication Guide that comes with zolpidem tartrate tablets
before you start taking it and each
time you get a refill. There may be new information. This Medication
Guide does not take the place of
talking to your doctor about your medical condition or treatment.
What is the most important information I should know about zolpidem
tartrate tablets?
After taking zolpidem tartrate tablets, you may get up out of bed
while not being fully awake and do an
activity that you do not know you are doing. The next morning, you may
not remember that you did
anything during the night. You have a higher chance for doing these
activities if you drink alcohol or take
other medicines that make you sleepy with zolpidem tartrate tablets.
Reported activities include:
•
driving a car ("sleep-driving")
•
making and eating food
•
talking on the phone
•
having sex
•
sleep-walking
Call your doctor right away if you find out that you have done any of
the above activities after taking
zolpidem tartrate tablets.
Important:
1. Take zolpidem tartrate tablets exactly as prescribed
•
Do not take more zolpidem tartrate tablets than prescribed.
•
Take zolpidem tartrate tablets right before you get in bed, not
sooner.
2. Do not take zolpidem tartrate tablets if you:
•
drink alcohol
•
take other medicines that can make you sleepy. Talk to your doctor
about all of your medicines.
Your doctor will tell you if you can take zolpidem tartrate tablets
with your other medicines.
•
cannot get a full night's sleep
What are zolpidem tartrate tablets?
Zolpidem tartrate tablets are a sedative-hypnotic (sleep) medicine.
Zolpidem tartrate tablets are used in
adults for the short-term treatment of a sleep problem called
insomnia. Symptoms of insomnia include:
•
trouble falling asleep
Zolpidem tartrate tablets are not for children.
Zolpidem tartrate tablets are a fede

제품 특성 요약

ZOLPIDEM TARTRATE- ZOLPIDEM TARTRATE TABLET, FILM COATED
DR. REDDY'S LABORATORIES LIMITED
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
ZOLPIDEM TARTRATE TABLETS SAFELY AND
EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ZOLPIDEM TARTRATE
TABLETS.
ZOLPIDEM TARTRATETABLETS C_IV_
INITIAL U.S. APPROVAL: 1992
RECENT MAJOR CHANGES
Indications and Usage (1) 03/2007
Warnings and Precautions (5)
Severe anaphylactic and anaphylactoid reactions (5.2) 03/2007
Abnormal thinking and behavioral changes (5.3) 03/2007
Special populations (5.6) 03/2007
INDICATIONS AND USAGE
Zolpidem tartrate tablets are indicated for the short-term treatment
of insomnia characterized by difficulties with sleep
initiation. Zolpidem tartrate tablets have been shown to decrease
sleep latency for up to 35 days in controlled clinical
studies. (1)
DOSAGE AND ADMINISTRATION
Adult dose: 10 mg once daily immediately before bedtime (2.1)
Elderly/debilitated patients/hepatically impaired: 5 mg once daily
immediately before bedtime (2.2)
Downward dosage adjustment may be necessary when used with CNS
depressants (2.3)
Should not be taken with or immediately after a meal (2.4)
DOSAGE FORMS AND STRENGTHS
5 mg and 10 mg tablets. Tablets not scored. (3)
CONTRAINDICATIONS
Known hypersensitivity to zolpidem tartrate or to any of the inactive
ingredients in the formulation (4)
WARNINGS AND PRECAUTIONS
Need to evaluate for co-morbid diagnosis: Reevaluate if insomnia
persists after 7 to 10 days of use (5.1)
Severe anaphylactic/anaphylactoid reactions: Angioedema and
anaphylaxis have been reported. Do not rechallenge if
such reactions occur. (5.2)
Abnormal thinking, behavioral changes and complex behaviors: May
include "sleep-driving" and hallucinations.
Immediately evaluate any new onset behavioral changes. (5.3)
Depression: Worsening of depression or, suicidal thinking may occur.
Prescribe the least amount feasible to avoid
intentional overdose (5.3, 5.6)
Withdrawal effects: Symptoms may occur wit